Bone Formation in the Maxillary Sinus by Using Platelet-Rich Plasma: An Experimental Study in Sheep
The purpose of this study was to quantitatively evaluate the ability of PRP to enhance bone regeneration in the maxillary sinus of sheep when combined with demineralized freeze-dried bone allograft (DFDBA) and cortical cancellous freeze-dried bone allograft (CCFDBA).
Bone Formation in the Maxillary Sinus by Using Platelet-Rich Plasma: An Experimental Study in Sheep
The purpose of this study was to quantitatively evaluate the ability of PRP to enhance bone regeneration in the maxillary sinus of sheep when combined with demineralized freeze-dried bone allograft (DFDBA) and cortical cancellous freeze-dried bone allograft (CCFDBA).
Evaluation of the Adjunctive Benefits of Platelet-Rich Plasma in Subantral Sinus Augmentation
The purpose of this randomized, single-blinded, controlled study was to compare bone formation after subantral maxillary sinus augmentation with freeze-dried bone allograft (FDBA) plus PRP versus FDBA plus resorbable membrane.
Comparison of the Platelet Concentrate Collection System With the Plasma-Rich-in-Growth-Factors Kit to Produce Platelet-Rich Plasma: A Technical Report
The aim of this study was to compare a new method for the production of platelet-rich plasma (PRP), the plasma-rich-in-growth-factors kit (PRGF kit; G.A.C. Medicale San Antonio, Vitoria, Spain), with an established method, the Platelet Concentrate Collection System (PCCS; 3i/Implant Innovations, Palm Beach Gardens, FL) with respect to resulting cellular and growth factor contents.
Evaluation of the Adjunctive Benefits of Platelet-Rich Plasma in Subantral Sinus Augmentation
The purpose of this randomized, single-blinded, controlled study was to compare bone formation after subantral maxillary sinus augmentation with freeze-dried bone allograft (FDBA) plus PRP versus FDBA plus resorbable membrane.
Comparison of the Platelet Concentrate Collection System With the Plasma-Rich-in-Growth-Factors Kit to Produce Platelet-Rich Plasma: A Technical Report
The aim of this study was to compare a new method for the production of platelet-rich plasma (PRP), the plasma-rich-in-growth-factors kit (PRGF kit; G.A.C. Medicale San Antonio, Vitoria, Spain), with an established method, the Platelet Concentrate Collection System (PCCS; 3i/Implant Innovations, Palm Beach Gardens, FL) with respect to resulting cellular and growth factor contents.
Evaluation of the Adjunctive Benefits of Platelet-Rich Plasma in Subantral Sinus Augmentation
The purpose of this randomized, single-blinded, controlled study was to compare bone formation after subantral maxillary sinus augmentation with freeze-dried bone allograft (FDBA) plus PRP versus FDBA plus resorbable membrane.
Emergency Endovascular Interventions for Acute Thoracic Aortic Rupture: Four-Year Follow-up
It was our objective to evaluate whether emergency endovascular interventions would improve the outcomes of these patients.
Emergency Endovascular Interventions for Acute Thoracic Aortic Rupture: Four-Year Follow-up
It was our objective to evaluate whether emergency endovascular interventions would improve the outcomes of these patients.
Dynamic and Differential Changes in Myocardial and Plasma Endothelin in Patients Undergoing Cardiopulmonary Bypass
The bioactive peptide endothelin modulates left ventricular function by changing afterload, coronary vascular tone, and myocardial contractility.
Perturbations in Laboratory Values After Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass
The purpose of this study was to describe the sequential changes in commonly obtained laboratory values after coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB).
Polarized Arrest With Warm or Cold Adenosine/Lidocaine Blood Cardioplegia is Equivalent to Hypothermic Potassium Blood Cardioplegia
This study tested the hypothesis that elective arrest in a polarized state with adenosine (400 mumol/L via adenosine triphosphate-sensitive potassium channel opening) and the Na + channel blocker lidocaine (750 mumol/L) as the arresting agents in blood cardioplegia provides cardioprotection comparable to standard hypothermic K + -blood cardioplegia.